Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma.
Hölting TLB, Cidre-Aranaz F, Matzek D, Popper B, Jacobi SJ, Funk CM, Geyer FH, Li J, Piseddu I, Cadilha BL, Ledderose S, Zwilling J, Ohmura S, Anz D, Künkele A, Klauschen F, Grünewald TGP, Knott MML.
Hölting TLB, et al. Among authors: matzek d.
Mol Cancer. 2022 Oct 13;21(1):199. doi: 10.1186/s12943-022-01641-6.
Mol Cancer. 2022.
PMID: 36229873
Free PMC article.